Name | BIOLEK, OOO |
|---|
INN | 5046053660 |
|---|
KPP | 401101001 |
|---|
OGRN | 1024000693771 |
|---|
OKPO | 45746228 |
|---|
Address | 249061, Kaluzhskaya Oblast', r-n Maloyaroslavetskiy, s Kudinovo |
|---|
Phone | 9-53-61 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 02.12.2002 |
|---|
Registering department | Administratsiya goroda Troitska Moskovskoy oblasti |
|---|
|
BIOLEK, OOO (Kaluga Oblast; INN 5046053660) was registered on 2 Dec 2002. The company's authorized capital as of July 1, 2012 was 14370 rub. Type of ownership of BIOLEK, OOO - Limited liability companies. Form of ownership of BIOLEK, OOO - Private property. Principal activities of BIOLEK, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of BIOLEK, OOO grew over 2023 by 15.09% to 1.07 million RUB from 928.00 thousand RUB over 2022, the company informed. Revenue increased in the accounting period by 10.15% to 61.87 million RUB from 56.17 million RUB over 2022. 2022
Net profit (RAS) of BIOLEK, OOO dropped in 2022 by 31.76% to 928.00 thousand RUB from 1.36 million RUB over the same period in 2021, the company informed. Revenue increased in the accounting period by 5.80% to 56.17 million RUB from 53.09 million RUB over 2021. 2021
Net profit (RAS) of BIOLEK, OOO dropped in 2021 2.56 times to 1.36 million RUB from 3.48 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 2.68% to 53.09 million RUB from 54.55 million RUB in 2020. 2020
Net profit (RAS) of BIOLEK, OOO grew over 2020 by 45.32% to 3.48 million RUB from 2.39 million RUB over 2019, the company informed. Revenue increased in the accounting period by 26.23% to 54.55 million RUB from 43.22 million RUB over 2019. 2019
Net profit (RAS) of BIOLEK, OOO grew over 2019 by 7.13% to 2.39 million RUB from 2.23 million RUB over 2018, the company informed. Revenue increased in the accounting period by 17.73% to 43.22 million RUB from 36.71 million RUB over 2018. 2018
Net profit (RAS) of BIOLEK, OOO grew over 2018 by 32.46% to 2.23 million RUB from 1.68 million RUB over 2017, the company informed. Revenue increased in the accounting period by 9.41% to 36.71 million RUB from 33.55 million RUB over 2017; cost of goods sold grew by 8.86% to 28.12 million RUB from 25.84 million RUB; sales profit went up by 26.67% to 2.73 million RUB from 2.15 million RUB. 2017
Net profit (RAS) of BIOLEK, OOO grew over 2017 12.84 times to 1.68 million RUB from 131.00 thousand RUB over 2016, the company informed. Revenue remained in the accounting period at the same level and made up 33.55 million RUB compared to 33.65 million RUB 33.65 million RUB; cost of goods sold decreased by 7.07% to 25.84 million RUB from 27.80 million RUB; sales profit went up 4.36 times to 2.15 million RUB from 494.00 thousand RUB. 2016
Net profit (RAS) of BIOLEK, OOO dropped in 2016 30.43 times to 131.00 thousand RUB from 3.99 million RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 13.11% to 33.65 million RUB from 29.75 million RUB over 2015; cost of goods sold grew by 33.89% to 27.80 million RUB from 20.76 million RUB; sales profit fell 8.80 times to 494.00 thousand RUB from 4.35 million RUB. 2014
Net profit (RAS) of BioLek, OOO grew over 2014 2.16 times to 1.37 million RUB from 636.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 40.12% to 26.33 million RUB from 18.79 million RUB over 2013; cost of goods sold grew by 38.15% to 20.10 million RUB from 14.55 million RUB; sales profit went up 1.91 times to 1.69 million RUB from 882.00 thousand RUB. 2013
Net profit (RAS) of BioLek, OOO dropped in 2013 by 46.82% to 636.00 thousand RUB from 1.20 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 2.14% to 18.79 million RUB from 18.40 million RUB over 2012; cost of goods sold decreased by 14.25% to 14.55 million RUB from 16.97 million RUB; sales profit fell by 38.15% to 882.00 thousand RUB from 1.43 million RUB. 2012
Net profit (RAS) of BioLek, OOO made up 1.20 million RUB over 2012 compared to net loss of 250.00 thousand RUB over 2011, the company informed. Revenue increased in the accounting period by 20.38% to 18.40 million RUB from 15.28 million RUB over 2011; cost of goods sold grew by 11.23% to 16.97 million RUB from 15.26 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|